impactbiomedinc.com (IBO) - Company Cash on Hand

IBO (Impact BioMedical Inc) - company brandmark

Commercialization prospects for the patent developments of Impact BioMedical Inc (IBO) remain distant, and current costs are already priced in. An opaque ownership structure and weak management negatively impact capitalization. This chart on GURU.Markets displays the cash on hand metric, where the value stands at 0.00. Meanwhile, the holding company is effectively scaling the business through intellectual property management without inflating headcount.

IBO - impactbiomedinc.com Company Cash Funds over the range 09/17/2024 - 11/20/2026

Summary analytical data breakdowns for Impact BioMedical, Inc. (IBO)

- current price and projected stock value:
Fundamental company analysis:impactbiomedinc.com
Signature product of Impact BioMedical

This metric serves as a key indicator of the issuer's solvency and operational viability. The metric tracks daily liquid asset balances, allowing for an assessment of the business's real margin of safety outside the scope of quarterly reports. By analyzing cash capital dynamics, an investor determines the company's ability to withstand market shocks. For Impact BioMedical Inc (IBO), this reserve is critically important when scaling costly oncological research. Sufficient liquidity ensures the stable development of the b2b patent licensing strategy.

Competitors of Impact BioMedical Inc (IBO)

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance